


Importing Chinese herbal ingredients is not a one-certificate job. This guide separates customs paperwork, regulatory filings, plant-health documents, and lot-level quality evidence, then shows where real importers get trapped by mismatched names, weak COAs, and illegal claims.
Paperwork decides clearance.
An importer may have a clean, correctly dried lot of Angelica sinensis root or Astragalus membranaceus slices, yet still lose time and money when the invoice, plant part, batch code, FDA filing, APHIS status, and laboratory records tell different stories.
Why gamble?
The direct answer is that there is no universal document pack for every botanical and every country. The required file changes with the destination, intended use, species, plant part, processing level, shipment mode, and label claims. In the United States, the same consignment can touch U.S. Customs and Border Protection, FDA, USDA APHIS, and—when a protected species is involved—the CITES permit system. FDA also makes an important point many sellers blur: imported foods are not individually “approved” before shipment; they must comply with the law, come from properly registered facilities when required, and arrive with Prior Notice. FDA’s food import guidance spells that out.
I use the U.S. as the detailed working model below because it exposes the full problem: customs clearance, food regulation, plant-health control, and quality verification are separate systems. Importers in the EU, Great Britain, and Canada should build the same core dossier, then check TRACES, IPAFFS, or CFIA AIRS for destination-specific controls.
To import Chinese herbal ingredients, build three connected document layers before freight is booked:
That separation matters. A certificate of analysis cannot replace FDA Prior Notice. A phytosanitary certificate cannot repair an inaccurate commercial invoice. And a GMP or ISO 22000 certificate does not prove that lot GC-260714-03 passed Pb, As, Cd, Hg, pesticide, aflatoxin, moisture, sulfur dioxide, and microbiological limits.
Before approving a seller, I would compare the document promise against a practical Chinese herbal slices supplier checklist and then pressure-test the records through a Chinese herb supplier audit process. Certificates are useful. Certificate worship is not.

The table below separates documents that are normally present on every commercial shipment from documents that are conditional. “Conditional” does not mean optional; it means the trigger depends on the product and route.
| Document | Typical status | Who prepares or files it | What I check before shipment |
|---|---|---|---|
| Commercial invoice | Almost always required | Chinese exporter or seller | Legal buyer and seller names, detailed botanical description, common and Latin name, plant part, product form, quantity, unit price, total value, currency, country of origin, Incoterm, and consistent package marks |
| Packing list | Almost always required | Exporter or packing facility | Carton count, bag count, net and gross weight, dimensions, lot numbers, pallet marks, and exact agreement with the invoice and transport booking |
| Bill of lading or air waybill | Required for transport | Carrier or freight forwarder | Shipper, consignee, notify party, package count, weight, ports, container number, seal number, and product description |
| Customs entry data and CBP Form 7501 | Required for formal U.S. entry | Importer or licensed customs broker | Importer of record, HTS classification, entered value, origin, manufacturer identity, duty data, and agency flags |
| Customs bond and broker power of attorney | Commonly required for formal U.S. imports | Importer and surety/broker | Correct legal entity, importer number, bond sufficiency, scope of authority, and current signatures |
| Importer Security Filing, “ISF 10+2” | Required for most U.S. vessel cargo | U.S. importer or filing agent | Filing no later than 24 hours before cargo is loaded, with manufacturer, seller, buyer, consignee, stuffing location, consolidator, origin, HTS, and other required data |
| FDA Prior Notice | Required for most imported food unless exempt | Importer, broker, carrier, or authorized filer | Product identity, manufacturer, shipper, arrival information, country of production, FDA product code, and confirmation number |
| FDA food facility registration and U.S. agent details | Required for most covered foreign food facilities | Foreign manufacturer, processor, packer, or holder | Active registration, exact facility address, recognized UFI, product categories, and valid U.S. agent relationship |
| FSVP records | Required for many U.S. food imports, with exemptions and modified rules | U.S. FSVP importer | Hazard analysis, supplier evaluation, verification activity, corrective actions, approval status, and records for the specific food-supplier combination |
| APHIS import permit and phytosanitary certificate | Conditional | U.S. importer plus exporting-country plant authority | Exact species, plant part, origin, end use, processing form, additional declarations, treatments, and approved port conditions |
| CITES permit or certificate | Conditional for listed species or derivatives | Exporter and sometimes importer | Scientific name, Appendix status, source code, quantity, permit validity, stamps, and consistency with invoice and packages |
| Certificate of analysis, product specification, and identity evidence | Commercially essential; legally relevant to verification and GMP controls | Manufacturer and qualified laboratory | Exact lot number, methods, limits, numerical results, lab identity, approval signature, botanical identity, plant part, origin, and release date |
| Certificate of origin, organic certificate, treatment record, allergen statement, GMO statement, irradiation declaration | Conditional | Exporter, certifier, competent authority, or manufacturer | Claim scope, lot or shipment link, destination rule, certificate validity, and consistency with labels and sales claims |
CBP requires an adequate merchandise description, quantities, and values on the commercial invoice; formal-entry records use CBP Form 7501, bonds are required for almost all formal entries, and brokers generally need a valid power of attorney. Its ISF rule applies to vessel cargo and can carry monetary consequences when filings are late or inaccurate. FDA separately requires Prior Notice for covered imported food, and its FSVP rule assigns verification responsibility to a U.S. importer rather than to the foreign factory.
The biggest paperwork mistake happens earlier than most buyers think. They ask, “Which certificates can you provide?” before answering, “What is this product under the destination country’s law?”
A sliced root sold to a tea blender, a powdered botanical sold to a dietary supplement manufacturer, and a finished TCM formula sold with disease-treatment claims are not the same regulatory proposition. In the U.S., disease claims can push a product into unapproved-drug territory even when the seller calls it a supplement. FDA’s 2024 warning letter to Far East Summit cited TCM products for undeclared extract solvents, missing plant-part identification, nonstandard ingredient names, deficient Supplement Facts information, and claims-related violations.
This is why “traditional use” is not a customs classification. Nor is “herbal medicine.” I want the importer to define one primary use: food ingredient, tea ingredient, dietary supplement ingredient, cosmetic ingredient, research material, or medicinal product. Then the label, invoice wording, tariff code, facility scope, FSVP program, and quality specification must follow that decision.
Glycyrrhiza uralensis root slices, whole Cinnamomum cassia bark, viable herb seed, fresh rhizomes, sterilized powder, and an alcohol extract do not present the same pest pathway. USDA APHIS states that requirements vary by commodity and country of origin and directs importers to its Agricultural Commodity Import Requirements database. APHIS also maintains a list of generally authorized non-propagative plant products that may not need a permit or other APHIS requirements, although all consignments remain subject to inspection.
So no, every dried herb does not automatically need a phytosanitary certificate. But no responsible importer should assume that “dried” means exempt. Whole seeds, minimally processed plant parts, fresh materials, protected plants, materials carrying soil, and certain origin-product combinations deserve a commodity-specific check before the purchase order is signed.
A website may group plant, animal, and mineral medicinals under one commercial catalog, but border agencies do not. Animal-derived TCM ingredients can trigger wildlife, veterinary, animal-health, or endangered-species controls; mineral products can raise chemical composition, heavy-metal, drug, or hazardous-material questions. Importers should separate these SKUs from plant-only herbs at quotation stage, not after the container is sealed.
For plant-based sourcing, a wholesale Chinese medicinal herbs supplier should be able to state the accepted common name, Latin binomial, plant part, growing or collection origin, processing form, batch code, and intended destination market without improvising.

I have one rule: every identifier must match.
The legal manufacturer name on FDA registration should match the manufacturing site in the supplier file. The lot number on the COA should match the inner bag and outer carton. The botanical description on the invoice should match the specification. The plant part on the label should match what was actually cut, milled, or extracted. The net weight on the packing list should reconcile with the bill of lading.
A vague description such as “Chinese herbs,” “herbal powder,” “plant extract,” or “medicine material” invites questions. Use a defensible description such as “dried sliced Angelica sinensis root, non-propagative, for dietary supplement manufacturing” or “powdered Astragalus membranaceus root, no added ingredients, food-grade botanical raw material.” CBP explicitly warns against vague cargo descriptions and publishes examples of acceptable versus unacceptable wording.
At minimum, I want the invoice to show the seller, buyer, consignee when different, invoice number and date, purchase-order reference, country of origin, detailed product name, Latin name, plant part, form, lot or batch reference where practical, package count, net weight, unit price, total price, currency, Incoterm, and tariff code used by the importer.
Hard truth: writing a softer or vaguer description to “avoid attention” is not clever. It creates inconsistency across CBP, FDA, APHIS, the broker entry, and the physical labels. That inconsistency can become evidence that the importer did not exercise reasonable care.
A serious certificate of analysis for herbal ingredients should state the product name, Latin binomial, plant part, lot number, manufacturing or packing date, specification limits, actual results, analytical methods, laboratory identity, approval status, and release signature. For risk-ranked botanicals, the panel may include Pb, As, Cd, Hg, pesticide residues, aflatoxins B1/B2/G1/G2, total aerobic count, yeast and mold, E. coli, Salmonella, moisture or loss on drying, sulfur dioxide, foreign matter, and relevant marker compounds.
“Pass” is not data.
A COA that reports “heavy metals: conforms” without numerical values, methods, or limits may be useful for sales. It is weak evidence for an importer trying to defend supplier approval, investigate a complaint, or compare the result against a destination-market limit. The better approach is to define the specification first, approve the test panel, and retain both the supplier COA and independent verification data where risk justifies it.
The site’s 15 process control points from raw herb to sliced product and its page on custom processing, COA testing, and export documentation are useful internal follow-ons because they connect receiving inspection, slicing, milling, packaging, batch control, and shipment records instead of treating the COA as an isolated PDF.
This distinction is routinely misunderstood. The Foreign Supplier Verification Program under 21 CFR Part 1, Subpart L requires the responsible U.S. importer to evaluate hazards and supplier performance, choose suitable verification activities, address failures, and maintain records, subject to exemptions and modified requirements. A foreign factory cannot simply email an “FSVP certificate” and transfer the importer’s legal responsibility. FDA’s FSVP overview is blunt about who owns the obligation.
For a botanical ingredient, the FSVP file should connect the hazard analysis to the specification and verification plan. Think species substitution, undeclared plant part, Pb/As/Cd/Hg, pesticide residues, Salmonella, mycotoxins, allergens from shared equipment, sulfur treatment, solvent residues for extracts, and economically motivated adulteration. The test panel should follow the risk. Not fashion.
A phytosanitary certificate for herbs is required when the destination plant-health authority says that the exact commodity-origin-use combination must be certified as meeting its import conditions. In the U.S., the correct sequence is to search APHIS ACIR, confirm whether a permit is needed, review any treatment or additional-declaration language, and determine whether the exporting country’s national plant protection organization must issue a certificate.
Do this before production. A phytosanitary certificate is not a document a factory should casually promise after the vessel closes, because inspection, treatment, official endorsement, or port-routing conditions may have to be arranged in advance.
The same logic applies elsewhere. The EU uses TRACES for animal and plant-health certification and certain food or feed controls; Great Britain uses IPAFFS for covered imports; Canada directs importers to AIRS for commodity-specific rules. These systems are not interchangeable, and a certificate accepted in one market does not automatically satisfy another.
From the enforcement files I reviewed, the recurring failures are not exotic. They are missing plant parts, nonstandard ingredient names, contaminant blind spots, weak manufacturing records, and claims that quietly change the product’s legal category.
New York Wholesale Group recalled Zaarah Herbals Rasayan Churan, Gurmar Powder, Vasaka Powder, and Bhringraj Powder because the products had the potential to contain elevated lead and arsenic. The lesson is not that one brand failed. The lesson is that Pb and As risk belongs in supplier qualification, lot testing, and release decisions for botanical powders.
FDA’s warning letter to Far East Summit addressed TCM products including Ba Zheng Tang, Bu Zhong Yi Qi Tang, and Er Chen Tang. Among the cited issues were failure to declare an extract solvent, use of “Citrus” rather than an adequate common or usual name, and failure to identify the plant part. That is a direct warning to importers who treat bilingual botanical nomenclature as a translation detail instead of a compliance control.
FDA’s letter to American Chinese Natural Herbs cited dietary supplement CGMP violations and multiple labeling failures, including nonstandard common names, missing plant parts, bilingual-label defects, and numerical inconsistencies between capsule weight and declared ingredient totals. Paperwork was not separate from product quality; it was the record of whether the company controlled the product at all.
The border-enforcement scale is also larger than many small importers assume. In FY 2024, USDA APHIS’s Smuggling Interdiction and Trade Compliance program conducted 17,650 surveys and made 3,782 seizures; 559 seizures occurred in express-courier facilities, and the seized prohibited or restricted material totaled 208,791 pounds with an estimated value of about $1.9 million. These figures cover agricultural products broadly, not Chinese herbs alone, but they show that small parcels and plant materials are active enforcement channels.
The best way to import Chinese herbal ingredients is to build the admissibility file before issuing the final purchase order, then freeze the product description, specification, label language, and document responsibilities in writing.
Here is the sequence I trust:
The controversial opinion? Importers should stop asking suppliers for “all certificates.” It is lazy procurement language. Ask for named records tied to named regulations and this lot. You will get fewer PDFs and better evidence.
To import Chinese herbal ingredients, an importer normally needs a commercial invoice, packing list, transport document, customs entry data, and—depending on the destination, intended use, botanical species, plant part, and processing level—FDA or equivalent food filings, an FSVP record, an APHIS permit, a phytosanitary certificate, or CITES permits.
The quality dossier should also include a signed specification, lot-specific COA, identity evidence, traceability records, contaminant results, processing declarations, and current facility certificates. Those records may not all be handed to customs, but they support importer verification and a defensible release decision.
A phytosanitary certificate for herbs is an official plant-health document issued by the exporting country’s national plant protection organization, but it is required only when the destination authority regulates that exact species, plant part, origin, and product form; many fully dried, non-propagative products may be admissible without one.
Check the destination database by scientific name and origin before ordering. In the U.S., use APHIS ACIR and confirm whether a permit, certificate, treatment, additional declaration, inspection, or restricted port is specified.
A certificate of analysis for herbal ingredients is a lot-specific laboratory and release record that identifies the botanical, plant part, batch number, test methods, specification limits, and numerical results for hazards such as Pb, As, Cd, Hg, pesticide residues, aflatoxins, moisture, sulfur dioxide, and microbiological contamination.
I also want the laboratory name, report date, sample identifier, approval signature, test units, method references, and a clear pass/fail decision against the importer-approved specification. A generic template or a report for a different lot should be rejected.
FSVP is the U.S. Foreign Supplier Verification Program, a risk-based importer system requiring the responsible U.S. party to evaluate the foreign supplier, analyze known hazards, select verification activities, correct failures, and keep records for each imported food, subject to exemptions and modified rules for certain categories.
It is not a certificate sold by a factory or broker. For Chinese botanical ingredients, the FSVP file should connect supplier performance, botanical identity, contaminant hazards, testing, audits, and corrective actions to the exact food and supplier.
Chinese herbal ingredients can be imported as foods or dietary supplement ingredients only when their identity, composition, manufacturing controls, labels, and claims fit that legal category; disease-treatment claims, undeclared solvents, missing plant parts, or noncompliant ingredient names can cause FDA to treat finished products as misbranded or unapproved drugs.
The importer should review the intended use and claims before shipment, not after labels are printed. FDA facility registration, Prior Notice, applicable FSVP or modified requirements, dietary supplement CGMP responsibilities, and compliant U.S. labeling may all need to be addressed.
Do not send a deposit based on a sample photo and a generic COA. Send the supplier a document matrix listing the destination country, common and Latin name, plant part, product form, intended use, annual volume, packaging, required tests, labeling language, permit status, and party responsible for every filing.
Then ask for one complete mock lot dossier.
Use the specification, COA panel, packing marks, and export-record requirements above, then contact GuoCao with the destination market and ingredient list. The actionable request is simple: “Show me the exact documents for this species, this plant part, this lot, and this country before we ship.”